DataMeds AI, Inc. Depreciation
DataMeds AI, Inc. (MEDS) reported Depreciation of $27.64 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-17
- DataMeds AI, Inc. depreciation for the quarter ending 2026-06-30 was $27.64K, a 30.44% decline year-over-year.
- DataMeds AI, Inc. depreciation for the quarter ending 2026-03-31 was $27.86K, a 30.01% decline year-over-year.
- DataMeds AI, Inc. depreciation for the quarter ending 2025-12-31 was $39.53K, a 2.24% decline year-over-year.
- DataMeds AI, Inc. depreciation for the quarter ending 2025-09-30 was $39.73K, a 46.21% increase year-over-year.
- DataMeds AI, Inc. depreciation for fiscal 2025 was $158.80K, a 134.86% increase from fiscal 2024.
- DataMeds AI, Inc. depreciation for fiscal 2024 was $67.62K.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $27.64K 10-Q · filed 2026-08-17 | $55.50K 10-Q · filed 2026-08-17 | $95.03K derived: sum of 3 quarters · filed 2026-08-17 | $134.76K derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | $27.86K 10-Q · filed 2026-05-19 | $67.40K derived: sum of 2 quarters · filed 2026-05-19 | $107.13K derived: sum of 3 quarters · filed 2026-05-19 | $146.86K derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | $39.53K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | $79.27K derived: sum of 2 quarters · filed 2026-03-20 | $119.00K derived: sum of 3 quarters · filed 2026-08-17 | $158.80K 10-K · filed 2026-03-20 |
| 2025-09-30 | $39.73K 10-Q · filed 2025-11-19 | $79.46K derived: sum of 2 quarters · filed 2026-08-17 | $119.27K 10-Q · filed 2025-11-19 | $159.71K derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | $39.73K 10-Q · filed 2026-08-17 | $79.54K 10-Q · filed 2026-08-17 | $119.98K derived: sum of 3 quarters · filed 2026-08-17 | $147.15K derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | $39.81K 10-Q · filed 2026-05-19 | $80.25K derived: sum of 2 quarters · filed 2026-05-19 | $107.42K derived: sum of 3 quarters · filed 2026-05-19 | $107.42K derived: sum of 4 quarters · filed 2026-05-19 |
| 2024-12-31 | $40.44K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-20 | $67.62K derived: sum of 2 quarters · filed 2026-03-20 | $67.62K derived: sum of 3 quarters · filed 2026-03-20 | $67.62K 10-K · filed 2026-03-20 |
| 2024-09-30 | $27.17K 10-Q · filed 2025-11-19 | $27.17K derived: sum of 2 quarters · filed 2025-11-19 | $27.17K 10-Q · filed 2025-11-19 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |